WPI 3659 (Desvenlafaxine Succinate Extended-Release 50 mg (base))
Pill with imprint WPI 3659 is Pink, Four-sided and has been identified as Desvenlafaxine Succinate Extended-Release 50 mg (base). It is supplied by Actavis Pharma, Inc.
Desvenlafaxine is used in the treatment of major depressive disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 50 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3659
Desvenlafaxine Succinate Extended-Release
- Imprint
- WPI 3659
- Strength
- 50 mg (base)
- Color
- Pink
- Size
- 12.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-3659 (Discontinued)
- Inactive Ingredients
-
hypromelloses,
microcrystalline cellulose,
magnesium silicate,
magnesium stearate,
silicon dioxide,
titanium dioxide,
ferric oxide yellow,
ferric oxide red,
propylene glycol,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about desvenlafaxine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,253)
- Drug images
- Pricing & coupons
- En español
- Drug class: serotonin-norepinephrine reuptake inhibitors
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.